Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/sudden-acceleration-of-diabetes-quality-measures-nejnq59ixv
- Publisher
- American Medical Association
- Copyright
- Copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
- ISSN
- 0098-7484
- eISSN
- 1538-3598
- DOI
- 10.1001/jama.2011.153
- pmid
- 21325188
- Publisher site
- See Article on Publisher Site
Abstract
COMMENTARY Sudden Acceleration of Diabetes Quality Measures sota Community Measurement Program developed a com- Leonard Pogach, MD, MBA posite measure, termed the Diabetes 5 (D5), that was based David C. Aron, MD, MS on these optimal measures for HbA , blood pressure, and 1c LDL-C; administration of aspirin; and nonsmoking status. HE MODERN ERA IN DIABETES PERFORMANCE MEA- Despite unanimous opposition from the Technical Ad- surement began in 1997, when the Diabetes Qual- visory Panel of the Alliance, the NCQA approved the opti- ity Improvement Project (DQIP), the first national mal measure set in May 2006. Even though inconsistent Tdisease-specific measure, set recommended thresh- with guidelines from nonspecialty societies, these mea- olds for intermediate outcomes (glycated hemoglobin [HbA ] sures were widely viewed as evidence-based standards of care 1c levels, blood pressure, and low-density lipoprotein choles- because they were based on the guidelines of specialty so- terol [LDL-C] levels). These thresholds, if not achieved, cieties that lent their leadership to the industry-sponsored would clearly result in greater population morbidity and mor- public service campaign. tality. The DQIP explicitly stated that such threshold mea- Coincidentally, 1 week after approval of the optimal mea- sures were neither guidelines nor standards and
Journal
JAMA – American Medical Association
Published: Feb 16, 2011